BC
AMGN icon

Barrett & Company’s Amgen AMGN Stock Holding History

Barrett & Company’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$340K Buy
939
+25
+3% +$8.56K 0.1% 116
2026
Q1 		$322K Buy
914
+3
+0.3% +$1.07K 0.11% 109
2025
Q4 		$298K Sell
911
-97
-10% -$30.8K 0.1% 113
2025
Q3 		$284K Buy
1,008
+4
+0.4% +$1.16K 0.1% 122
2025
Q2 		$280K Buy
1,004
+3
+0.3% +$850 0.11% 121
2025
Q1 		$312K Buy
1,001
+3
+0.3% +$886 0.13% 106
2024
Q4 		$260K Buy
998
+104
+12% +$30.9K 0.11% 118
2024
Q3 		$288K Buy
894
+3
+0.3% +$981 0.12% 112
2024
Q2 		$279K Buy
891
+3
+0.3% +$881 0.13% 113
2024
Q1 		$253K Sell
888
-147
-14% -$43K 0.12% 112
2023
Q4 		$298K Buy
1,035
+3
+0.3% +$817 0.16% 103
2023
Q3 		$277K Buy
1,032
+4
+0.4% +$998 0.16% 100
2023
Q2 		$228K Buy
1,028
+4
+0.4% +$928 0.13% 118
2023
Q1 		$248K Buy
1,024
+135
+15% +$33.1K 0.16% 108
2022
Q4 		$234K Hold
889
– – 0.15% 105
2022
Q3 		$234K Buy
+889
New +$215K 0.15% 105

Other funds holding AMGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Barrett & Company's AMGN Position: Q2 2026 in Review

Barrett & Company increased its Amgen (AMGN) stake by 2.7% in Q2 2026, buying an estimated $8.56K and bringing the position to 939 shares worth $340K. The position accounts for 0.1% of the portfolio, ranked #116.

Barrett & Company first reported a position in AMGN in Q3 2022 and has held it in 16 quarters since. 3,149 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Barrett & Company held 939 shares of Amgen worth $340K as of Q2 2026.
  • Barrett & Company bought 25 Amgen shares in Q2 2026, an estimated $8.56K.
  • Amgen made up 0.1% of Barrett & Company's portfolio in Q2 2026, its #116 holding.
  • Barrett & Company first reported a position in Amgen in Q3 2022 and has held it in 16 quarters since.
  • 3,149 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Barrett & Company's 13F filing for Q2 2026, filed 24 Jul 2026.